Viral evolution under the pressure of an adaptive immune system - optimal mutation rates for viral escape
Christel Kamp, Claus O. Wilke, Christoph Adami, Stefan Bornholdt

TL;DR
This paper models viral evolution under immune pressure, identifying optimal mutation rates that balance diversity and information retention, aligning with observed rates in viruses like HIV.
Contribution
It introduces a theoretical framework linking mutation rates to immune response timing, revealing conditions for viral survival and optimal mutation strategies.
Findings
Optimal mutation rate depends on immune response time and viral growth rate.
Viruses tend to generate one mutation within the immune adaptation period.
Observed viral mutation rates, such as in HIV, align with the model's predictions.
Abstract
Based on a recent model of evolving viruses competing with an adapting immune system [1], we study the conditions under which a viral quasispecies can maximize its growth rate. The range of mutation rates that allows viruses to thrive is limited from above due to genomic information deterioration, and from below by insufficient sequence diversity, which leads to a quick eradication of the virus by the immune system. The mutation rate that optimally balances these two requirements depends to first order on the ratio of the inverse of the virus' growth rate and the time the immune system needs to develop a specific answer to an antigen. We find that a virus is most viable if it generates exactly one mutation within the time it takes for the immune system to adapt to a new viral epitope. Experimental viral mutation rates, in particular for HIV (human immunodeficiency virus), seem to…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEvolution and Genetic Dynamics · HIV Research and Treatment · Artificial Immune Systems Applications
